• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经元蜡样脂褐质沉积症患儿大脑中的蛋白质模式改变。

Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis.

作者信息

Wisniewski K E, Gordon-Majszak W, Maslinski S, Heaney-Kieras J

机构信息

New York State Office of Mental Retardation and Developmental Disabilities, Department of Pathological Neurobiology, Staten Island 10314.

出版信息

Am J Med Genet. 1992 Feb 15;42(4):568-74. doi: 10.1002/ajmg.1320420429.

DOI:10.1002/ajmg.1320420429
PMID:1376969
Abstract

The neuronal ceroid lipofuscinoses (NCL) are a group of inherited neurodegenerative diseases characterized by massive intralysosomal accumulation of storage materials. We have studied the protein patterns in 5 NCL, 5 control, and one Alzheimer disease brains. When protein patterns in NCL and control brain gray matter homogenates were examined by SDS-PAGE, NCL brains showed an absence or greatly reduced amounts of the Mr 160-180 kDa component and reduced amounts of the Mr 29-36 kDa component. Concomitantly, an increase in several components with Mrs of 45-50 kDa was noted. The 180 kDa polypeptide appears to be a glycoprotein because it was bound to the lectins concanavalin A and Ulex europaeus. Recently, the abnormal processing of amyloid protein precursor (APP) and its potential role in NCL have been suggested. Possible defects in tissue proteases and protease inhibitors may be considered responsible for the presence of these amyloid beta protein precursor fragments. To examine this possibility we are using polyclonal antibodies to the C terminal 672-695 (APP) and monoclonal antibodies to inter-alpha-trypsin inhibitor. Polypeptides with molecular weights of approximately 35-38 kDa were detected in the NCL brain, but not in controls in both cases. These findings suggest abnormal protein processing in NCL brain tissue, disturbances in protein and glycoconjugate metabolism, impaired lysosomal function (i.e., metabolic enzyme and/or proteases/proteinase inhibitor abnormalities), and the involvement of improperly processed APP.

摘要

神经元蜡样脂褐质沉积症(NCL)是一组遗传性神经退行性疾病,其特征是溶酶体内大量储存物质积累。我们研究了5例NCL患者、5例对照者以及1例阿尔茨海默病患者大脑中的蛋白质模式。当通过SDS-PAGE检测NCL和对照者脑灰质匀浆中的蛋白质模式时,NCL患者的大脑显示出Mr 160 - 180 kDa成分缺失或含量大幅降低,以及Mr 29 - 36 kDa成分含量降低。同时,注意到几种Mr为45 - 50 kDa的成分有所增加。180 kDa多肽似乎是一种糖蛋白,因为它与伴刀豆球蛋白A和欧洲荆豆凝集素结合。最近,有人提出淀粉样蛋白前体(APP)的异常加工及其在NCL中的潜在作用。组织蛋白酶和蛋白酶抑制剂的可能缺陷可能被认为是这些淀粉样β蛋白前体片段存在的原因。为了研究这种可能性,我们正在使用针对C末端672 - 695(APP)的多克隆抗体和针对α-胰蛋白酶抑制剂的单克隆抗体。在NCL患者的大脑中检测到分子量约为35 - 38 kDa的多肽,但在两种情况下的对照者大脑中均未检测到。这些发现表明NCL脑组织中存在异常的蛋白质加工、蛋白质和糖缀合物代谢紊乱、溶酶体功能受损(即代谢酶和/或蛋白酶/蛋白酶抑制剂异常)以及加工不当的APP的参与。

相似文献

1
Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis.神经元蜡样脂褐质沉积症患儿大脑中的蛋白质模式改变。
Am J Med Genet. 1992 Feb 15;42(4):568-74. doi: 10.1002/ajmg.1320420429.
2
Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations.神经元蜡样脂褐质沉积症临床和病理表现的变异性:数据回顾与观察
Am J Med Genet. 1992 Feb 15;42(4):525-32. doi: 10.1002/ajmg.1320420420.
3
Altered amyloid beta-protein precursor processing in brains of patients with neuronal ceroid lipofuscinosis.神经元蜡样脂褐质沉积症患者大脑中淀粉样β蛋白前体加工过程的改变。
Neurosci Lett. 1990 Nov 27;120(1):94-6. doi: 10.1016/0304-3940(90)90176-a.
4
Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein.
Acta Neuropathol. 1990;80(1):26-34. doi: 10.1007/BF00294218.
5
Beta-protein immunoreactivity in brains of patients with neuronal ceroid lipofuscinosis: ultrastructural and biochemical demonstration.神经元蜡样脂褐质沉积症患者大脑中的β蛋白免疫反应性:超微结构和生化证明
Neurosci Lett. 1990 May 4;112(2-3):155-60. doi: 10.1016/0304-3940(90)90195-f.
6
Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses.神经元蜡样脂褐质沉积症中的神经退行性变机制。
Acta Neuropathol. 2006 Feb;111(2):168-77. doi: 10.1007/s00401-005-0024-x. Epub 2006 Feb 8.
7
Perspective of biochemical research in the neuronal ceroid-lipofuscinosis.神经元蜡样脂褐质沉积症的生化研究视角
Am J Med Genet. 1992 Feb 15;42(4):519-24. doi: 10.1002/ajmg.1320420419.
8
Diagnoses of neuronal ceroid-lipofuscinosis by immunochemical methods.通过免疫化学方法诊断神经元蜡样脂褐质沉积症。
Am J Med Genet. 1995 Jun 5;57(2):239-45. doi: 10.1002/ajmg.1320570226.
9
Protease inhibitors as a model for NCL disease, with special emphasis on the infantile and adult forms.蛋白酶抑制剂作为NCL疾病的模型,特别强调婴儿型和成人型。
Am J Med Genet. 1992 Feb 15;42(4):555-60. doi: 10.1002/ajmg.1320420427.
10
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL).成人神经元蜡样脂褐质沉积症(NCL)的形态学研究。
Clin Neuropathol. 1982;1(4):151-62.

引用本文的文献

1
Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses.用于疾病建模和评估婴儿型(CLN1/PPT1)和晚婴儿型(CLN2/TPP1)神经元蜡样脂褐质沉积症治疗药物的神经干细胞。
Orphanet J Rare Dis. 2018 Apr 10;13(1):54. doi: 10.1186/s13023-018-0798-2.
2
Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).婴儿神经元蜡样脂褐质沉积症(婴儿型CLN1病)的发病机制与治疗方法
Biochim Biophys Acta. 2013 Nov;1832(11):1906-9. doi: 10.1016/j.bbadis.2013.05.026. Epub 2013 Jun 6.
3
A clinical approach to early-onset inheritable dementia.
早发性遗传性痴呆的临床处理方法。
Am J Alzheimers Dis Other Demen. 2012 May;27(3):154-61. doi: 10.1177/1533317512444000.
4
S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.粟酒裂殖酵母btn1是巴滕病基因CLN3的直系同源物,是Cpy1p液泡蛋白分选和Vps10p高尔基体输出所必需的。
J Cell Sci. 2009 Apr 15;122(Pt 8):1163-73. doi: 10.1242/jcs.038323. Epub 2009 Mar 19.
5
Abnormal processing of carboxy-terminal fragment of beta precursor protein (beta PP) in neuronal ceroid-lipofuscinosis (NCL) cases.神经元蜡样脂褐质沉积症(NCL)病例中β-前体蛋白(β-PP)羧基末端片段的异常加工。
J Inherit Metab Dis. 1993;16(2):312-6. doi: 10.1007/BF00710273.